Bioversys AG Net Asset Momentum
Bioversys AG net asset momentum. Bioversys AG (BIOV) recorded a net asset momentum of 459.9% as of December 2025, with net assets of CHF59.81 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore BIOV cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Bioversys AG (2024–2025)
Net asset momentum of Bioversys AG from 2024 to 2025. This chart tracks Bioversys AG's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is +459.9%, with net assets of CHF59.81 Million CHF as of December 2025. See shareholders equity of Bioversys AG for net asset value and shareholders' equity analysis.
Bioversys AG Net Asset Momentum by Year (2024–2025)
Bioversys AG net asset momentum by year from 2024 to 2025. The table below shows the complete annual net asset history for Bioversys AG from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Bioversys AG market capitalisation.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CHF59.81 Million | CHF90.64 Million | CHF30.82 Million | ▲ +459.9% |
| 2024 | CHF10.68 Million | CHF34.96 Million | CHF24.27 Million | — |